Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma

Leukemia. 2017 Aug;31(8):1816-1819. doi: 10.1038/leu.2017.124. Epub 2017 Apr 25.

¹ Division of Hematology and Medical Oncology, Würzburg University Medical Center, Würzburg, Germany.
² Department of Internal Medicine III, University of Ulm, Ulm, Germany.
³ Department of Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany.
⁴ Hematology and Oncology, Jena University Hospital, Jena, Germany.
⁵ Department of Hematology and Medical Oncology, University of Regensburg, Regensburg, Germany.
⁶ Hematology and Oncology, Erlangen University Hospital, Erlangen, Germany.
⁷ Department of Hematology and Oncology, University Hospital Rechts der Isar, Munich, Germany.
⁸ Hematology and Oncology, Bremen-Mitte Clinic, Bremen, Germany.
⁹ Hematology and Oncology, Charité Campus Virchow, Berlin, Germany.
¹⁰ Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.
¹¹ Department of Hematology, University Hospital Großhadern, Munich, Germany.
¹² Medical Center, Nürnberg Nord Hospital, Nürnberg, Germany.
¹³ Third Department of Medicine, Karlsruhe Hospital, Karlsruhe, Germany.
¹⁴ Second Department of Medicine, Division of Stem Cell Transplantation and Immunotherapy, University of Kiel, Kiel, Germany.
¹⁵ Department of Medicine, Clinic III (Hematology/Oncology/Palliative Care), University Medical Center, Rostock, Germany.
¹⁶ Hematology and Oncology, Schleswig-Holstein University Hospital, Lübeck, Germany.
¹⁷ ClinAssess GmbH, Leverkusen, Germany.

No abstract available

Publication types